scispace - formally typeset
C

Charles Ramassamy

Researcher at Institut national de la recherche scientifique

Publications -  99
Citations -  5460

Charles Ramassamy is an academic researcher from Institut national de la recherche scientifique. The author has contributed to research in topics: Oxidative stress & Neuroprotection. The author has an hindex of 35, co-authored 91 publications receiving 4825 citations. Previous affiliations of Charles Ramassamy include Université du Québec & Laval University.

Papers
More filters
Journal ArticleDOI

Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets

TL;DR: Increasing number of studies demonstrated the efficacy of polyphenolic antioxidants from fruits and vegetables to reduce or to block neuronal death occurring in the pathophysiology of these disorders, and revealed that other mechanisms than the antioxidant activities could be involved in the neuroprotective effect of these phenolic compounds.
Journal ArticleDOI

Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms.

TL;DR: The focus of this review is aimed at presenting the role of some polyphenols from fruits, vegetables, and beverages in neuroprotection and particularly in Alzheimer's disease and the research challenges in this area.
Journal ArticleDOI

The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid.

TL;DR: The results suggest that the neuroprotective effects of EGb 761 are partly associated with its antioxidant properties and highlight its possible effectiveness in neurodegenerative diseases, e.g. AD via the inhibition of Aβ‐induced toxicity and cell death.
Journal ArticleDOI

Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage.

TL;DR: The antioxidant effects of DHEA are investigated in models of oxidative stress using rat primary hippocampal cells and human hippocampal tissue from AD patients and age-matched controls to suggest that D HEA may be useful in treating age-related central nervous system diseases based on its protective effects in the hippocampus.